Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Octimet Oncology NV

www.octimet.com

Latest From Octimet Oncology NV

Venture Funding Deals

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in January and February 2017.

Commercial StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Belgium
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Octimet Oncology NV
  • Senior Management
  • Tim Perera, PhD, CEO
    Philip Owen, CFO
    Ann Meulemans, PhD, Chief Dev. Officer
    Glen Clack, MD, CMO
    Thomas Stohr, PhD, COO
  • Contact Info
  • Octimet Oncology NV
    Phone: 473 558 353
    Turnhoutsebaan 30
    Beerse, 2340
    Belgium
Advertisement
Advertisement
UsernamePublicRestriction

Register